| Literature DB >> 31309060 |
Sadrollah Motamed1, Peyman Mohammadi Torbati2, Hamid Zaferani Arani3, Amir Reza Motabar4, Amirhossein Zabolian3, Zahra Madadi5,6.
Abstract
BACKGROUND: Cartilage grafts are generally accepted for the restoration and reconstruction of nasal contours. The main concern that plastic surgeons may need to address after surgery pertains to the resorption and disfigurement of the grafted cartilage, especially in allogenic and heterogenic grafts.Entities:
Keywords: Amniotic membrane; Cartilage; Graft; Rabbit
Year: 2019 PMID: 31309060 PMCID: PMC6620805 DOI: 10.29252/wjps.8.2.219
Source DB: PubMed Journal: World J Plast Surg ISSN: 2228-7914
Fig. 1Illustrations of the methodology for preparation and placing of cartilages. Six subcutaneous pockets were created 3 cm from back midline and 5 cm from each other (A). Right column wrapped and left column is bare grafts. Upper row block grafts, middle row crushed grafts that made by hemostate and inferior row diced grafts (B)
Fig. 2Histology of the different shapes of cartilages with different staining. Matrix demonstrates Safranin-O uptake by the matrix, which is an important evidence of viability of the diced fragments of HAM wrapped in autograft (Safranin-O, ×200) (A). Complete cartilage resorption and replacement by inflamed and neovascularized fibrous tissue in block and crushed heterograft (H&E, ×200, ×400) (B and C). Fibroblast prolifation in diced unwrapped allograft (Verhoeff–Van Gieson, ×200) (D). Positive immunoreactivity for Glial fibrillary acidic protein in crushed HAM Wrapped autogrft cartilage indicating a regeneration capacity (Verhoeff–Van Gieson, ×400) (E)
Information about different types of staining in specimens
|
|
|
|
|
|---|---|---|---|
| Hematoxylin and Eosin | Nuclear chromatin and lacunar glycosaminoglycans | Dark blue | Viable chondrocytes maintain nucleated lacunae |
| Safranin-o | Proteoglycan content | Red | Viable chondrocytes produce proteoglycan matrix |
| Masson’s trichrome | Collagen content | Green | Used to compare with normal cartilage |
| Van Gieson | Elastic fibers | Brown | Normal component of cartilage; for comparison across groups |
| Glial fibrillary acidic protein | Intermediate filaments | Brown in cytoplasm | Part of a mechanotransduction system by which potentially regenerative cells respond |
Viability description and grading system
|
|
|
|---|---|
| 1 | Complete resorption, severe bone formation |
| 2 | Multifocal resorption >50% or moderate bone formation |
| 3 | Focal resorption <50% or minimal bone formation |
| 4 | Point resorption <10% |
| 5 | Viable tissue, no resorption |
The amount of every 4 outcomes by 3 groups of graft and 3 shapes of cartilage (Each square describes a rabbit)
|
| ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
| |||||||||||||||||||||
|
|
|
|
|
|
| |||||||||||||||||||
| Autograft | 4 | 4 | 5 | 5 | 5 | 5 | 4 | 5 | 3 | 4 | 3 | 3 | 4 | 4 | 3 | 5 | 2 | 3 | 2 | 2 | 4 | 3 | 3 | 4 |
| Allograft | 4 | 4 | 5 | 4 | 4 | 5 | 5 | 3 | 2 | 3 | 3 | 2 | 3 | 2 | 4 | 4 | 3 | 2 | 1 | 2 | 3 | 2 | 3 | 2 |
| Heterograft | 3 | 3 | 3 | 4 | 4 | 5 | 4 | 4 | 2 | 1 | 2 | 2 | 2 | 2 | 2 | 3 | 2 | 1 | 1 | 1 | 2 | 1 | 1 | 2 |
| Proliferation | ||||||||||||||||||||||||
| Autograft | 1 | 2 | 1 | 1 | 2 | 2 | 2 | 2 | 1 | 2 | 1 | 2 | 2 | 2 | 1 | 2 | 2 | 1 | 1 | 2 | 2 | 1 | 2 | 1 |
| Allograft | 1 | 2 | 1 | 2 | 2 | 2 | 1 | 2 | 2 | 1 | 1 | 1 | 2 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 |
| Heterograft | 1 | 1 | 2 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 2 |
| Vascularity | ||||||||||||||||||||||||
| Autograft | 2 | 3 | 2 | 2 | 3 | 2 | 2 | 3 | 1 | 2 | 1 | 1 | 3 | 2 | 3 | 3 | 2 | 2 | 1 | 1 | 3 | 2 | 3 | 2 |
| Allograft | 3 | 2 | 2 | 3 | 3 | 3 | 2 | 3 | 3 | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 2 | 3 | 2 | 2 | 3 | 2 | 2 | 3 |
| Heterograft | 1 | 1 | 2 | 2 | 2 | 1 | 1 | 2 | 1 | 2 | 1 | 1 | 2 | 1 | 2 | 2 | 1 | 2 | 1 | 1 | 2 | 1 | 2 | 1 |
| Inflammatory | ||||||||||||||||||||||||
| Autograft | 1 | 1 | 1 | 2 | 1 | 2 | 1 | 1 | 2 | 1 | 3 | 1 | 2 | 1 | 1 | 2 | 3 | 2 | 3 | 3 | 3 | 2 | 2 | 3 |
| Allograft | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 2 | 2 | 2 | 1 | 2 | 1 | 1 | 2 | 3 | 3 | 3 | 2 | 2 | 2 | 3 | 2 | 3 |
| Heterograft | 1 | 2 | 2 | 1 | 2 | 2 | 1 | 2 | 2 | 2 | 1 | 3 | 2 | 2 | 1 | 2 | 1 | 2 | 1 | 2 | 2 | 1 | 2 | 2 |